Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT00766948

The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry

By creating a neurogenebank from Parkinson's disease patients' blood donations we will ultimately be able to define genes for Parkinson's disease and other neurological conditions.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Parkinson's Disease Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases Movement Disorders Nervous System Diseases Neurodegenerative Diseases Parkinson Disease Parkinsonian Disorders Synucleinopathies

Age range

30 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Scripps Clinic, Torrey Pines, La Jolla, California, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Is age 30 years or older at the time of onset of Parkinson's
  • Has been diagnosed with idiopathic Parkinson's Disease by a Scripps Neurologist
  • Is reliable, cooperative and willing to comply with all protocol-specified procedures and/or sub-study if consented or have legal representative/guardian willing to do so
  • Able to understand and grant informed consent or have a legal representative/ guardian who is able to do so

Exclusion criteria

  • Patient has been previously enrolled in The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry
  • If a blood draw would be contraindicated for any reason
  • Has a significant chronic medical condition (i.e. CVA, hepatic encephalopathy) which, in the investigator's option, may interfere with the patient's optimal participation in the study
  • Treatment with any investigational agents or devices within 30 days preceding enrollment in the study
  • Has undergone ECT within 90 days preceding enrollment in the study

Treatment and study plan

There is no intervention, this is a biorepository.

Other

There are no interventions in this study.

Primary outcomes

  1. Neurogenetic databank

    Time frame: Study completion

    initiate a Parkinson's disease neurogenetic databank by obtaining blood samples in order to define genes for Parkinson's disease and other neurological conditions.

Sponsors and collaborators

Lead sponsor

Scripps Translational Science Institute

Other

Collaborators

  • Scripps Health
  • The Scripps Research Institute

Registry information

Important dates

Study start
2008
Primary completion
2030
Study completion
2030
First posted
Oct 6, 2008
Registry last updated
Jan 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.